Extreme Life, Biospeology & Astrobiology - International Journal of the Bioflux Society
Published by Bioflux - annual.
ISSN 2067-6360 (online); ISSN 2066-7671 (print)
Contact for submission: Ionel-Claudiu Gavriloaie, ionelclaudiu@yahoo.com
ELBA Bioflux welcomes original articles, reviews, minireviews, short notes, letters, opinions and editorials on extremophilic species, extreme behavior or metabolism, cave species or communities, astrobiology, evolution, cryopreservation, enzymology, microbiology and lichenology.
Our journal, ELBA Bioflux, is a good opportunity for you to publish your papers on time, color, both printed and online, open access, unlimited pages. The journal allows the author(s) to hold the copyright without restrictions. This is an open-access journal distributed under the terms of the Creative Commons Attribution License CC-BY, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
ELBA Bioflux is an international peer-reviewed journal. Each published article was independently seen before by two Scientific Reviewers and at least one lingvist. Peer-review policy in ELBA Bioflux: double blind peer-review. The editors use a soft for screening the plagiarism. Acceptance rate: about 65%. Electronic submission is required.
Because many authors withdrew their manuscript in final form just before the payment of the publication fee, our policy has changed (20 February 2019). The publication fee was replaced by a processing fee (100 USD), which is paid after a preliminary evaluation (not at the end). Our evaluation has two steps. 1)A preliminary evaluation by the editor (the author gets a preliminary acceptance or rejection); 2)An external double blind peer-review (at this point the author gets a final decision: acceptance or rejection). Please note that if the manuscript will not be published, the author or his/her institution gets the money back (except the cases of poor feedback from authors or withdrawal/rejection due to multiple submissions). We inform the authors about our final decision (acceptance or rejection) in 3-8 weeks after their submission. The average overall time from submission of the manuscript to publication is 10 weeks. Faster processing involves a tax of priority (50 USD).
Manuscript processing fee: 100 USD (or equivalent in EURO or RON);
Manuscript processing fee with priority: 150 usd (or equivalent in EURO or RON);
Publication fee: 0 USD.
The journal has a waiver policy for developing country authors (only for cases of very good quality manuscripts). When the manuscript's first author is a member of the Editorial Board Expanded (ELBA Bioflux), there is no processing fee. Please attach a scanned payment document and email to zoobiomag2004@yahoo.com
Payment to: Bioflux SRL
SWIFT CODE of the bank: BTRLRO22
Account no. 213USDCRT00L2861401
IBAN:
USD: RO68BTRL01302202L28614XX BANCA TRANSILVANIA (Cluj-Napoca)
EURO: RO19BTRL01304202L28614XX BANCA TRANSILVANIA (Cluj-Napoca)
RON: RO44BTRL01301202L28614XX BANCA TRANSILVANIA (Cluj-Napoca)
Statement of human and animal rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed (International Committee of Medical Journal Editors - "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"- February 2006 – cited by Pubmed, Medline database).
Statement of informed consent
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note (International Committee of Medical Journal Editors - "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"- February 2006 – cited by Pubmed, Medline database).
Conflict-of-interest statement
Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself (International Committee of Medical Journal Editors - "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"- February 2006 – cited by Pubmed, Medline database). However, conflicts can occur for other reasons, such as personal relationships, academic competition or intellectual passion, and the Chief Editor will do his best to avoid them, using specific policies in the process of peer-review.
Authors responsibilities
- All authors have significantly contributed to the research
- All authors are obliged to provide retractions or
corrections of mistakes, in case of detection
- List of references should be provided by authors
- Information on financial support should be provided by
authors in Acknowledgement section
- It is forbidden to publish same research in more than one journal.
Peer-review, publication policies and publication ethics
- Judgments is external and objective
- Reviewers have no conflict of interest
- Reviewed articles are treated confidentially prior to
their publication
- Bioflux Publishing House takes reasonable steps to
identify and prevent the publication of papers where research misconduct has
occurred
- In the event that the publisher or editors are made aware
of any allegation of research misconduct the publisher or editor shall deal
with allegations appropriately
- Corrections, clarifications, retractions and apologies are
accepted. Correction of any published article after the official publication
date is not allowed in the same document. A scientific journal is not a
website. Corrections, clarifications and apologies written by the authors are
allowed by separate Note or Erratum. Retracting of a manuscript is made by
publisher in the case when plagiarism or other particular issues are reported.
- This is an open-access journal distributed under the terms
of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and
source are credited.
- In the case that our journal is no longer published,
Bioflux Publishing House has agreements with several databases which are
allowed to conserve and republish the old content at any time and unlimited
number of copies, both as electronic and hardcopies. Bioflux Publishing House
is archived by The Legal Deposit Bucharest (National Library) and by The County
Legal Deposit in Cluj-Napoca (Octavian Goga Library).
ELBA Bioflux
Model of paperVolume 18(1)/2026 (December, 30)
Volume 17(1)/2025 (December, 30)
Volume 16(1)/2024 (December, 30)
Volume 15(1)/2023 (December, 30)
Volume 14(1)/2022 (December, 30)
Volume 13(1)/2021 (December, 30)
Volume 12(1)/2020 (December, 30)
Volume 11(1)/2019 (December, 30)
Volume 10(1)/2018 (December, 30)
Volume 9(1)/2017 (December, 30)
Volume 8(2)/2016 (December, 30)
Volume 7(2)/2015 (December, 30)
Volume 6(2)/2014 (December, 15)
Volume 5(2)/2013 (December, 15)
Volume 4(2)/2012 (December, 30)
Volume 3(2)/2011 (December, 12)
Volume 2(2)/2010 (December, 15)
Volume 1(2)/2009 (December, 30)
Volume 1(1)/2009 (November, 30)
Volume Pilot (b)/2008 (December, 30) - available printed only
Volume Pilot (a)/2007 (December, 30) - available printed only